fish oil triglycerides · Fresenius Kabi Usa · NDA 210589
Omegaven
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210589 · 001 · RLD | emulsion, intravenous | 5GM/50ML (0.1GM/ML) | open |
| 210589 · 002 · RLD | emulsion, intravenous | 10GM/100ML (0.1GM/ML) | open |
Expired or delisted (1)
- US 9566260 · product, use U-2366 · 30 Jul 2026